内容へ

オンコロジー(小児)

血小板減少症の治療管理

Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children. (新しいタブで開く)

Ali S, Gassas A, Kirby-Allen M, Krueger J, Ali M, Schechter T

出典‎: Pediatr Transplant 2017;21(6):e13017.

インデックス‎: PubMed 28653480

DOI‎: 10.1111/petr.13017

https://www.ncbi.nlm.nih.gov/pubmed/28653480 (新しいタブで開く)

Romiplostim for immune thrombocytopenia in neuroblastoma patients receiving chemotherapy. (新しいタブで開く)

Fassel H, Bussel JB, Roberts SS, Modak S

出典‎: J Pediatr Hematol Oncol 2019;41(4):e257-9.

インデックス‎: PubMed 29683946

DOI‎: 10.1097/MPH.0000000000001187

https://www.ncbi.nlm.nih.gov/pubmed/29683946 (新しいタブで開く)

Romiplostim for therapy-related thrombocytopenia in pediatric malignancies. (新しいタブで開く)

Jacobson AE, Shah N, Setty BA

出典‎: Pediatr Blood Cancer 2017;64(8):e26473.

インデックス‎: PubMed 28150377

DOI‎: 10.1002/pbc.26473

http://www.ncbi.nlm.nih.gov/pubmed/28150377 (新しいタブで開く)

Eltrombopag for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation in children. (新しいタブで開く)

Li S, Wu R, Wang B, Fu L, Zhu G, Zhou X, Ma J, Zhang L, Qin M

出典‎: J Pediatr Hematol Oncol 2019;41(1):38-41.

インデックス‎: PubMed 30080752

DOI‎: 10.1097/MPH.0000000000001263

https://www.ncbi.nlm.nih.gov/pubmed/30080752 (新しいタブで開く)

Romiplostim for secondary thrombocytopenia following allogeneic stem cell transplantation in children. (新しいタブで開く)

Maximova N, Zanon D, Rovere F, Maestro A, Schillani G, Paparazzo R

出典‎: Int J Hematol 2015;102(5):626-32.

インデックス‎: PubMed 26084627

DOI‎: 10.1007/s12185-015-1821-1

https://www.ncbi.nlm.nih.gov/pubmed/26084627 (新しいタブで開く)

Chemotherapy induced thrombocytopenia in pediatric oncology. (新しいタブで開く)

Tamamyan G, Danielyan S, Lambert MP

出典‎: Crit Rev Oncol Hematol 2016;99:299-307.

インデックス‎: PubMed 26811139

DOI‎: 10.1016/j.critrevonc.2016.01.005

https://www.ncbi.nlm.nih.gov/pubmed/26811139 (新しいタブで開く)

Oncological management of pediatric cancer patients belonging to Jehovahs Witnesses: a two-institutional experience report. (新しいタブで開く)

Tenenbaum T, Hasan C, Kramm CM, Janssen G, Laws HJ, Wessalowski R, Bode U, Göbel U

出典‎: Onkologie 2004;27(2):131-7.

インデックス‎: PubMed 15138344

DOI‎: 10.1159/000076901

https://www.ncbi.nlm.nih.gov/pubmed/15138344 (新しいタブで開く)

Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. (新しいタブで開く)

Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, Kurzrock R.

出典‎: Ann Oncol 2005;16(1):139-45.

インデックス‎: PubMed 15598951

DOI‎: 10.1093/annonc/mdi007

https://www.ncbi.nlm.nih.gov/pubmed/15598951 (新しいタブで開く)

Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. (新しいタブで開く)

Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Daoud A, Fackler-Schwalbe I, Fischer J, Gäckle R, Geer T, Harms P, Löffler B, Ohl S, Otremba B, Raab M, Schönrock-Nabulsi P, Strobel G, Winter R, Link H

出典‎: Blood 1998;91(10):3601-6.

インデックス‎: PubMed 9572994

https://www.ncbi.nlm.nih.gov/pubmed/9572994 (新しいタブで開く)